About Inspira Technologies Oxy BHN
Inspira Technologies Oxy BHN (NASDAQ:IINN) is a pioneering medical technology firm focused on developing innovative respiratory support solutions. Their main project revolves around the ART system, a revolutionary approach designed to enhance oxygenation in patients facing respiratory failure, potentially reducing the need for mechanical ventilation. Inspira Technologies aims to transform respiratory care by making treatments more accessible, less invasive, and more efficient, thereby improving patient outcomes and reducing healthcare costs. With a strong commitment to innovation and patient care, Inspira Technologies is dedicated to advancing their research and development to broaden their portfolio of solutions and address the critical needs within the respiratory care space.
Snapshot
Operations
Produtos e/ou serviços de Inspira Technologies Oxy BHN
- Development of the ART system, a revolutionary respiratory support technology designed to enhance oxygenation.
- Innovations in minimally invasive extracorporeal CO2 removal systems to treat respiratory distress.
- Comprehensive respiratory solutions aimed at reducing the need for mechanical ventilation.
- Advanced oxygenation products tailored for critical care and emergency use.
- Development of portable extracorporeal blood purification devices for acute care settings.
- Research into next-generation technologies for non-invasive respiratory support.
equipe executiva do Inspira Technologies Oxy BHN
- Mr. Dagi Shahar Ben-NoonCo-Founder, CEO & Director
- Ms. Yafit TehilaChief Financial Officer
- Mr. Avi ShabtaiCOO and VP of Research & Development
- Ms. Daniella Yeheskely-Hayon Ph.D.Chief Technology Officer
- Ms. Sivan OzeriAdministrative Manager
- Adi ShmueliDirector of Marketing
- Mr. Mike HershkovitzVice President of Global Sales